(HealthDay News) -- A 2-in-1 tablet called Janumet to treat diabetes has been approved by the U.S. Food and Drug Administration, drug maker Merck & Co. said.
Latest MedicineNet News
Janumet contains a new Merck diabetes drug called Januvia and an older diabetes drug called metformin, the Associated Press reported. Some type 2 diabetes patients already take Januvia and metformin separately. This combined drug is designed to make it easier for patients to control their blood sugar levels, according to Merck.
Januvia, approved by the FDA last October, enhances the body's own ability to lower blood sugar levels.
Novartis AG has applied to the FDA for approval of a similar drug called Galvus, the AP reported.
-- Robert Preidt
Copyright © 2007 ScoutNews, LLC. All rights reserved.